Four MicroPort® Products Gain Regulatory Approval in Serbia
Belgrade, Serbia – Recently, Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") gained regulatory approval from the Ministry of Health in Serbia for four of its in-house developed cardiovascular products - Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®"), WALTZ™ CoCr Coronary Stent System ("WALTZ™"), Foxtrot™ NC PTCA Balloon Catheter ("Foxtrot™ NC"), and Foxtrot™ Pro PTCA Balloon Catheter ("Foxtrot™ Pro"). This is the first time for MicroPort® products to gain regulatory approval in Serbia.
The revolutionary third-generation drug-eluting stent ("DES") Firehawk® is the result of eight years of research and development of MicroPort® and it is the world's first and only target eluting stent. As the world's lowest drug dosage stent, Firehawk® combines the merits of the bare metal stent and DES. It adopts unique in-groove abluminal coating design and target-eluting technique, which allow Firehawk® to achieve the same clinical efficacy with significantly low drug loading, benefiting vascular early healing. WALTZ™ is indicated for the treatment of coronary artery stenosis or occlusion. WALTZ™ has strong radial strength and excellent flexibility, crossability, trackability, and pushability to achieve the best surgical outcome. Foxtrot® Pro is also indicated for pre-dilating the stenotic atherosclerotic lesions of coronary artery disease to facilitate the implantation of stent. The product offers multiple solutions for complex diseases with excellent crossability and trackability. Foxtrot® NC is indicated for pre-dilation as well as post-dilation. It has excellent crossability, trackability and pushability.
With a population of seven million, Serbia has a growing market for cardiovascular products. After the four products gained regulatory approval in Serbia, MicroPort® further expands its overseas markets. In the future, MicroPort® will continue to bring in more high-quality medical devices to the Serbia market to benefit more local patients.
Privacy settings
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.
For more information, please see our Cookie Policy.